9V3-11434-85685
4 vaccinations
6 coded responses
33 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 941 / CA
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
- 2021-04-21
- 2021-04-23
- 2021-05-03
-
2021-05-08
Survey response — day 28, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: My autoimmune meds arent working well since i had my second shot and im symptomatic again.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-14
- 2021-05-21
-
2021-07-09
Survey response — 3 months, dose 2MedDRA: Balance disorder, Nervous system disorder, Physiotherapy, Vision blurred — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Nerve problems in my hips and unsteadiness and periods of vision blur · Healthcare visit (other): Physical therapy and MRI'sMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-19
-
2021-07-20
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-09
Survey response — 6 months, dose 2MedDRA: Pregnancy, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Pregnancy · Healthcare visit (other): Ultrasounds and bloodworkMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-12
Dose 3 — Pfizer-BioNTech
-
2021-10-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-14
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-15
Call successfulCompleted over the phone
-
2021-10-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-26
- 2021-11-04
- 2021-11-09
- 2021-11-18
- 2021-11-25
- 2022-01-11
-
2022-04-12
Survey response — 6 months, dose 3MedDRA: COVID-19, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I had COVID-19 and had to get an antibody infusion at the beginning of February 2022. · Healthcare visit (other): Covid-19 antibody infusionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-13
-
2022-04-14
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-12
Dose 4 — Pfizer-BioNTech
-
2022-09-13
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-14
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-16
- 2022-09-18
- 2022-09-19
-
2022-09-20
Survey response — day 7, dose 5MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
- 2022-10-06
- 2022-10-19
- 2022-10-27
-
2022-12-19
Survey response — 3 months, dose 5MedDRA: Nasopharyngitis, SARS-CoV-2 test negative, Viral infection — Feeling: FairFree text: Ive got a cold or virus but am covid negative after 3 testsMedDRA releases: 2024-11 · check-in free text available
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-05-12 | Pfizer-BioNTech | No |
| 5 | 2022-09-13 | Pfizer-BioNTech | Flu |
Call center
4 call center cases
4 successful
VAERS report filed, before or during a call: 1
Free text
Release 8 — day 28, dose 2
Symptoms: My autoimmune meds arent working well since i had my second shot and im symptomatic again.
Release 9 — 3 months, dose 2
Symptoms: Nerve problems in my hips and unsteadiness and periods of vision blur
Healthcare visit (other): Physical therapy and MRI's
Release 10 — 6 months, dose 2
Release 11 — 6 months, dose 3
Symptoms: I had COVID-19 and had to get an antibody infusion at the beginning of February 2022.
Healthcare visit (other): Covid-19 antibody infusion
Release 12 — day 7, dose 5
Systemic reaction (other): Sore throat
Release 12 — 3 months, dose 5
Symptoms: Ive got a cold or virus but am covid negative after 3 tests
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Physiotherapy | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nervous system disorder | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release